37.74 0.00 (0.00%)
After hours: 4:22PM EST
|Bid||37.62 x 900|
|Ask||37.79 x 800|
|Day's Range||37.54 - 38.40|
|52 Week Range||35.03 - 69.79|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||18.22|
|Forward Dividend & Yield||1.48 (3.89%)|
|Ex-Dividend Date||Nov 25, 2019|
|1y Target Est||N/A|
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]
Nu Skin (NUS) is battling headwinds in Mainland China thanks to increased scrutiny by the government. Also, management provides an unimpressive view for 2019.
Nu Skin (NUS) delivered earnings and revenue surprises of 3.95% and -2.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Shares of Nu Skin Enterprises Inc. fell more than 7% in the extended session Tuesday after the maker of supplements and personal care products reported third-quarter earnings above expectations but sales missed the mark. Nu Skin earned $44 million, or 79 cents a share, in the quarter, compared with $53 million, or 94 cents a share, in the year-ago quarter. Revenue fell 13% to $590 million in the quarter, from $675 million a year ago, including a 23% drop in mainland China. Analysts polled by FactSet had expected GAAP profit of 76 cents a share on sales of $606 million. "Revenue came in slightly below expectation, primarily due to the challenging regulatory environment in mainland China, where meeting restrictions continued throughout the quarter," Nu Skin Chief Executive Ritch Wood said in a statement. Shares of Nu Skin had ended the regular trading day down 0.7%.
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of June 28. The results of that effort will be put on display in this article, as […]
Estee Lauder's (EL) strong online business and travel retail network are likely to drive growth. The company also benefits from a solid presence in emerging markets.
Nu Skin (NUS) is battling headwinds in Mainland China that led to an unimpressive view for 2019. However, a rising customer base bodes well.
Nu Skin (NUS) is battling headwinds in Mainland China, stemming from the government's campaign to scrutinize offerings of direct selling and health products industries.
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and -1.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?